Detalhe da pesquisa
1.
The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 51(3): 864-870, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935995
2.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682738
3.
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
Support Care Cancer
; 31(7): 425, 2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358628
4.
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.
J Oncol Pharm Pract
; 29(7): 1748-1753, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37282554
5.
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Oncologist
; 27(12): e949-e956, 2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920559
6.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180954
7.
Genomic correlates of clinical outcome in advanced prostate cancer.
Proc Natl Acad Sci U S A
; 116(23): 11428-11436, 2019 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31061129
8.
The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
Int J Mol Sci
; 22(13)2021 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34281219
9.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 162-174, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806540
10.
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Oncologist
; 25(10): e1509-e1515, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735386
11.
Targeting defective DNA repair in prostate cancer.
Curr Opin Oncol
; 32(5): 503-509, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32675592
12.
Clinical features and psychological aspects of the decision-making process in stage I testicular germ cell tumors.
Future Oncol
; 14(16): 1591-1599, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29956548
13.
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.
Radiology
; 283(1): 168-177, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27875103
15.
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review.
Front Oncol
; 14: 1338438, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38601761
16.
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis.
Eur Urol Oncol
; 7(2): 179-188, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37574390
17.
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9).
Clin Genitourin Cancer
; 22(2): 126-133.e2, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932204
18.
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.
Sci Rep
; 14(1): 4949, 2024 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418470
19.
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care.
Prostate Cancer Prostatic Dis
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347113
20.
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial.
Eur J Cancer
; 205: 114103, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38729054